Library Subscription: Guest
Critical Reviews™ in Immunology

Published 6 issues per year

ISSN Print: 1040-8401

ISSN Online: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Recognition of Melanoma-Derived Antigens by CTL: Possible Mechanisms Involved in Down-Regulating Anti-Tumor T-Cell Reactivity

Volume 18, Issue 1-2, 1998, pp. 55-63
DOI: 10.1615/CritRevImmunol.v18.i1-2.70
Get accessGet access

ABSTRACT

Several T cell-recognized epitopes presented by melanoma cells have been identified recently. Despite the large array of epitopes potentially available for clinical use, it is still unclear which of these antigens could be effective in mediating anti-tumor responses when used as a vaccine. Preliminary studies showed that immunization of melanoma patients with epitopes derived from proteins of the MAGE family may result in significant clinical regressions. However, no sign of systemic immunization could be observed in peripheral blood of treated patients. Conversely, significant immunization (detected as increased antigen-specific CTL activity in peripheral blood) was obtained by vaccinating HLA-A2.1+ melanoma patients with the immunodominant epitope (residues 27-35) of the differentiation antigen MART-1, but this immunization was not accompanied by a significant clinical response. To implement immunotherapeuties capable of significantly impacting disease outcome, it is necessary to identify the potential mechanisms responsible for the failure of some antigens to mediate significant anti-tumor responses in vivo. In the case of the MART-127.35 epitope, we hypothesize that one of these mechanisms may be related to the existence of natural analogs of this peptide in other human normal proteins.

CITED BY
  1. Somasundaram Rajasekharan, Robbins Paul, Moonka Dilip, Loh Elwyn, Marincola Francesco, Patel Amy, Guerry DuPont, Herlyn Dorothee, CD4+, HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cells, International Journal of Cancer, 85, 2, 2000. Crossref

  2. Noy Roy, Eppel Malka, Haus-Cohen Maya, Klechevsky Einav, Mekler Orian, Michaeli Yael, Denkberg Galit, Reiter Yoram, T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy, Expert Review of Anticancer Therapy, 5, 3, 2005. Crossref

  3. Rivoltini Licia, Carrabba Matteo, Huber Veronica, Castelli Chiara, Novellino Luisa, Dalerba Piero, Mortarini Roberta, Arancia Giuseppe, Anichini Andrea, Fais Stefano, Parmiani Giorgio, Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction, Immunological Reviews, 188, 1, 2002. Crossref

  4. Jantscheff Peter, Herrmann Richard, Rochlitz Christoph, Cancer gene and immunotherapy: recent developments, Medical Oncology, 16, 2, 1999. Crossref

  5. Rivoltini Licia, Canese Paola, Huber Veronica, Iero Manuela, Pilla Lorenzo, Valenti Roberta, Fais Stefano, Lozupone Francesco, Casati Chiara, Castelli Chiara, Parmiani Giorgio, Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?, Expert Opinion on Biological Therapy, 5, 4, 2005. Crossref

  6. Nemunaitis John, Fong Timothy, Shabe Peter, Martineau Darlene, Ando Dale, Comparison of Serum Interleukin-10 (IL-10) Levels Between Normal Volunteers and Patients with Advanced Melanoma, Cancer Investigation, 19, 3, 2001. Crossref

  7. Hudson Amy R., Smoller Bruce R., IMMUNOHISTOCHEMISTRY IN DIAGNOSTIC DERMATOPATHOLOGY, Dermatologic Clinics, 17, 3, 1999. Crossref

  8. Nielsen Mai-Britt, Kirkin Alexei F, Loftus Douglas, Nissen Mogens Holst, Rivoltini Licia, Zeuthen Jesper, Geisler Carsten, Odum Niels, Amino Acid Substitutions in the Melanoma Antigen Recognized by T Cell 1 Peptide Modulate Cytokine Responses in Melanoma-Specific T Cells, Journal of Immunotherapy, 23, 4, 2000. Crossref

  9. Rivoltini Licia, Parmiani Giorgio, Carrabba Matteo, Pilla Lorenzo, Altered peptide ligands of tumor T-cell epitopes, in Tumor Antigens Recognized by T Cells and Antibodies, 2003. Crossref

  10. Tyutyunyk-Massey Liliya, Haqqani Syed U., Mandava Reshma, Kentiba Kirubel, Dammalapati Mallika, Dao Nga, Haueis Joshua, Gewirtz David, Landry Joseph W., , 138, 2018. Crossref

  11. J�ger Elke, H�hn Hanni, Karbach Julia, Momburg Frank, Castelli Chiara, Knuth Alexander, Seliger Barbara, Maeurer Markus J., Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-A, International Journal of Cancer, 81, 6, 1999. Crossref

  12. Denkberg Galit, Lev Avital, Eisenbach Lea, Benhar Itai, Reiter Yoram, Selective Targeting of Melanoma and APCs Using a Recombinant Antibody with TCR-Like Specificity Directed Toward a Melanoma Differentiation Antigen, The Journal of Immunology, 171, 5, 2003. Crossref

  13. Kurnick James T., Ramirez-Montagut Teresa, Boyle Lenora A., Andrews David M., Pandolfi Franco, Durda Paul J., Butera David, Dunn Ian S., Benson Elizabeth M., Gobin Sam J. P., van den Elsen Peter J., A Novel Autocrine Pathway of Tumor Escape from Immune Recognition: Melanoma Cell Lines Produce a Soluble Protein That Diminishes Expression of the Gene Encoding the Melanocyte Lineage Melan-A/MART-1 Antigen Through Down-Modulation of Its Promoter, The Journal of Immunology, 167, 3, 2001. Crossref

  14. Castelli Chiara, Rivoltini Licia, Andreola Giovanna, Carrabba Matteo, Renkvist Nicolina, Parmiani Giorgio, T‐cell recognition of melanoma‐associated antigens, Journal of Cellular Physiology, 182, 3, 2000. Crossref

  15. Ramirez-Montagut T, Andrews D M, Ihara A, Pervaiz S, Pandolfi F, Van Den Elsen P J, Waitkus R, Boyle L A, Hishii M, Kurnick J T, Melanoma antigen recognition by tumour-infiltrating T lymphocytes (TIL): effect of differential expression of Melan-A/MART-1, Clinical and Experimental Immunology, 119, 1, 2002. Crossref

  16. Asai Tadao, Storkus Walter J., Whiteside Theresa L., Evaluation of the Modified ELISPOT Assay for Gamma Interferon Production in Cancer Patients Receiving Antitumor Vaccines, Clinical Diagnostic Laboratory Immunology, 7, 2, 2000. Crossref

  17. Denkberg Galit, Cohen Cyril J., Lev Avital, Chames Patrick, Hoogenboom Hennie R., Reiter Yoram, Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity, Proceedings of the National Academy of Sciences, 99, 14, 2002. Crossref

  18. Kono Michihiro, Dunn Ian S., Durda Paul J., Butera David, Rose Lenora B., Haggerty Timothy J., Benson Elizabeth M., Kurnick James T., Role of the Mitogen-Activated Protein Kinase Signaling Pathway in the Regulation of Human Melanocytic Antigen Expression, Molecular Cancer Research, 4, 10, 2006. Crossref

Forthcoming Articles

Identification of a novel five-gene prognostic model for laryngeal cancer associated with mitophagy using integrated bioinformatics analysis and experimental verification Dong Song, Lun Dong, Mei Wang, Xiaoping Gao Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effect of p-estrogen receptor at serine on its function and breast growth Yuan Liang, Junhui Qin, Tiancheng Ma, Tong Yang, Zhenyu Ke, Ruian Wang Mechanistic Insights into Tanshinone IIA in the Amelioration of Post-Thyroidectomy Hypoparathyroidism Xiaoyu Qian, Lin Li, Liang Chen, Chao Shen, Jian Tang MiRNA let-7d-5p alleviates inflammatory responses by targeting Map3k1 and inactivating ERK/p38 MAPK signaling in microglia Fan Fang, Cheng Chen Role of Natural Killer Cells as Cell-Based Immunotherapy in Oral Tumor Eradication and Differentiation Both In Vivo and In Vitro Kawaljit Kaur, Anahid Jewett The Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma Tu Nguyen, Po-Chun Chen, Janet Pham, Kawaljit Kaur, Steven Raman, Anahid Jewett, Jason Chiang Phillygenin alleviated arthritis through the inhibition of NLRP3 inflammasome and Ferroptosis by AMPK Jianghui Wang, Shufang Ni, Kai Zheng, Yan Zhao, peihong zhang, Hong Chang The value of systemic immune-inflammation index and T cell subsets in the severity and prognosis of sepsis Hao Zhou Efficacy and Nuances of Precision Molecular Engineering for Hodgkin's Disease to a Gene Therapeutic Approach Muhammad Imran Qadir, Bilal Ahmed, Nadir Hussain Serum interleukin 6 and ferritin levels are the independent risk factors for pneumonia in elderly patients Hao Yuan, Jing Tian, Lu Wen Exploration of diagnostic markers associated with inflammation in chronic kidney disease (CKD) based on WGCNA and machine learning Qianjia Wu, Yang Yang, Chongze Lin Clinical significance of serum CTRP3 level in the prediction of cardiac dysfunction and intestinal mucosal barrier dysfunction in patients with severe acute pancreatitis Qiang Shao, Lin Sun The protective effect and mechanism of mild hypothermia on pig lung injury after cardiopulmonary resuscitation Jinlin Ren, Fangfang Zhu, Dongdong Sang, Mulin Cong, Shujuan Jiang Exploring mechanism of Zilongjin in treating lung adenocarcinoma based on network pharmacology combined with experimental verification Kang Zhang, Xiaoqun Chen Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Genes Analysis Jian Shen, Minzhe Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei Identification of key ubiquitination-related genes and their associated with immune infiltration in osteoarthritis based on mRNA-miRNA network Dalu Yuan, Hailiang Shen, Lina Bai, Menglin Li, Qiujie Ye Diagnostic and Prognostic value of peripheral neutrophil CD64 index in elderly patients with community-acquired pneumonia Yan Li, Jing Zhang, Suhang Wang, Jie Cao Identification of Metabolism-Related Prognostic Biomarkers and Immune Features of Head and Neck Squamous Cell Carcinoma Rongjin Zhou, Junguo Wang Downregulation of miR-503-5p promotes the development of pancreatic cancer via targeting cyclin E2 Fei Li, Ying-pei Ling, Pan Wang, Shi-cheng Gu, Hao Jiang, Jie Zhu
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain